Nature Reviews Urology

Papers
(The H4-Index of Nature Reviews Urology is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Genomic and phenotypic heterogeneity in prostate cancer206
Epidemiology, definition and treatment of complicated urinary tract infections125
Epidemiology and genomics of prostate cancer in Asian men106
Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes95
Trained immunity as a molecular mechanism for BCG immunotherapy in bladder cancer90
The biology and rationale of targeting nectin-4 in urothelial carcinoma86
Could BCG be used to protect against COVID-19?85
Urology in the time of corona81
Genetics of kidney stone disease78
100 years of Bacillus Calmette–Guérin immunotherapy: from cattle to COVID-1977
The immune response to infection in the bladder76
Sperm ion channels and transporters in male fertility and infertility73
Sarcomatoid renal cell carcinoma: biology, natural history and management72
The need for urogenital tract monitoring in COVID-1970
Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours65
Molecular events in neuroendocrine prostate cancer development60
The diverse roles of SPOP in prostate cancer and kidney cancer57
Exercise-induced myokines and their effect on prostate cancer57
Cellular rewiring in lethal prostate cancer: the architect of drug resistance55
Resistance to second-generation androgen receptor antagonists in prostate cancer54
Defining cisplatin eligibility in patients with muscle-invasive bladder cancer54
Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future54
Late adverse effects and quality of life in survivors of testicular germ cell tumour46
Recurrence mechanisms of non-muscle-invasive bladder cancer — a clinical perspective45
An integrated model to assess and treat compulsive sexual behaviour disorder43
Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma40
Current evidence on screening for renal cancer39
Neoadjuvant hormonal therapy before radical prostatectomy in high-risk prostate cancer37
Understanding genomics and the immune environment of penile cancer to improve therapy36
Telehealth in urology after the COVID-19 pandemic36
Machine learning for sperm selection36
Transient receptor potential channels in sensory mechanisms of the lower urinary tract33
Making love in the time of corona — considering relationships in lockdown33
0.023673057556152